| Expression pattern: |
DN |
| Associated gene: |
LATS1 |
| Associated microRNA: |
miR-543 |
| Biological function: |
Suppresses colorectal cancer cell proliferation, migration and invasion; inhibits metastasis and progression |
| Molecular mechanism: |
Acts as a miR-543 sponge to increase LATS1 expression (ceRNA mechanism) |
| Biological pathway or process: |
ceRNA regulation (other); proliferation (inhibits); migration (inhibits); invasion (inhibits); metastasis (inhibits) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Luciferase Reporter Assay; RNA Pull-Down; Northern Blot; Western Blot; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
Downregulation of circ-FOXO3 was associated with poor overall survival of patients with CRC and associated with tumor size, distant metastasis, differentiation, lymph node metastasis and TMN stages |
| Description: |
circ-FOXO3 (hsa_circ_0006404) is down-regulated in colorectal cancer tissues and cell lines. Functionally, circ-FOXO3 suppresses CRC cell proliferation, migration and invasion by acting as a ceRNA that sponges miR-543 and thereby increases LATS1 expression. Low circ-FOXO3 expression is associated with poor overall survival and adverse clinicopathological features. |
| Confidence score: |
0.8244 |